(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-phenyl-propanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-5-oxo-pentanoyl]amino]-5-guanidino-pentanoyl]pyrrolidine-2-carbonyl]amino]-5-guanidino-pentanoyl]amino]-4-methyl-pentanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-2-methyl-propanoyl]amino]-3-(4-bromophenyl)propanoic acid

ID: ALA4550078

Chembl Id: CHEMBL4550078

PubChem CID: 155550782

Max Phase: Preclinical

Molecular Formula: C112H187BrN34O21

Molecular Weight: 2425.85

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCC)C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)O

Standard InChI:  InChI=1S/C112H187BrN34O21/c1-7-9-11-12-13-14-15-16-17-18-19-20-24-46-90(150)132-75(39-26-28-54-115)93(153)141-83(62-70-35-22-21-23-36-70)99(159)135-77(41-30-56-127-109(119)120)94(154)134-76(40-29-55-126-108(117)118)95(155)136-80(51-52-89(116)149)97(157)139-81(43-32-58-129-111(123)124)105(165)147-60-34-45-88(147)104(164)137-78(42-31-57-128-110(121)122)96(156)140-82(61-69(3)4)98(158)143-86(67-148)101(161)142-84(64-73-65-125-68-131-73)100(160)133-74(38-25-27-53-114)92(152)130-66-91(151)146-59-33-44-87(146)103(163)138-79(37-10-8-2)102(162)145-112(5,6)107(168)144-85(106(166)167)63-71-47-49-72(113)50-48-71/h21-23,35-36,47-50,65,68-69,74-88,148H,7-20,24-34,37-46,51-64,66-67,114-115H2,1-6H3,(H2,116,149)(H,125,131)(H,130,152)(H,132,150)(H,133,160)(H,134,154)(H,135,159)(H,136,155)(H,137,164)(H,138,163)(H,139,157)(H,140,156)(H,141,153)(H,142,161)(H,143,158)(H,144,168)(H,145,162)(H,166,167)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)(H4,123,124,129)/t74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-/m0/s1

Standard InChI Key:  FAVFJQCPNPIKSQ-LCGYCUFKSA-N

Alternative Forms

1. Parent:

   

   ALA4550078

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 2425.85

Molecular Weight (Monoisotopic): 2423.3793

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Fischer C, Lamer T, Wang W, McKinnie SMK, Iturrioz X, Llorens-Cortes C, Oudit GY, Vederas JC..  (2019)  Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents.,  166  [PMID:30690406] [10.1016/j.ejmech.2019.01.040]

Source

Source(1):

• Scientific Literature